 EDEN PRAIRIE, Minn., June 28, 2021 GLOBE NEWSWIRE -- Miromatrix Medical Inc. Nasdaq: MIRO Miromatrix, a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients lives, today announced the closing of its initial public offering of 5,520,000 shares of common stock, including the full exercise by the underwriter of its option to purchase 720,000 shares at a price to the public of 9.00 per share. The common stock is listed for trading on The Nasdaq Capital Market under the ticker symbol MIRO. 